As of 2025-07-14, the Intrinsic Value of Nova Mentis Life Science Corp (NOVA.CN) is -0.23 CAD. This NOVA.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.04 CAD, the upside of Nova Mentis Life Science Corp is -666.08%.
Based on its market price of 0.04 CAD and our intrinsic valuation, Nova Mentis Life Science Corp (NOVA.CN) is overvalued by 666.08%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.23 - -0.23 | -0.23 | -666.08% |
| P/E | (1.69) - (1.80) | (1.78) | -4540.9% |
| DDM - Stable | (0.33) - (0.88) | (0.61) | -1613.4% |
| DDM - Multi | (0.49) - (1.01) | (0.66) | -1745.2% |
| Market Cap (mil) | 1.45 |
| Beta | 3.07 |
| Outstanding shares (mil) | 36.29 |
| Enterprise Value (mil) | 1.50 |
| Market risk premium | 5.10% |
| Cost of Equity | 11.07% |
| Cost of Debt | 5.00% |
| WACC | 7.38% |